CSIR through the New Millennium Indian Technology Leadership Initiative (NMITLI) program approved a project towards the development of human monoclonal antibodies (hmAbs) that can neutralize SARS-CoV-2 in coronavirus infected patients. The project on the generation of neutralizing human ...
READ MORE +